Capital World InvestorsCapital World Investors

Institutional investor · Portfolio as of Q4 2025

SEC EDGAR SourceSEC Filings

Top Holdings574 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

BROADCOM INC

123.3M$42.7B5.8%$155.41+125.12%
27 qtrssince 2019-Q2
Decreased
0

MICROSOFT CORP

64.5M$31.2B4.2%$141.05+245.62%
27 qtrssince 2019-Q2
Decreased
0

META PLATFORMS INC-CLASS A

39.6M$26.1B3.6%$260.52+155.62%
27 qtrssince 2019-Q2
Increased
59

NVIDIA CORP

130.8M$24.4B3.3%$117.99+58.94%
18 qtrssince 2021-Q3
Decreased
0

PHILIP MORRIS INTERNATIONAL

132.4M$21.2B2.9%$78.95+105.13%
27 qtrssince 2019-Q2
Increased
56

TESLA INC

42.5M$19.1B2.6%$231.20+96.55%
27 qtrssince 2019-Q2
Decreased
0

ALPHABET INC-CL A

53.9M$16.9B2.3%$144.24+117.59%
27 qtrssince 2019-Q2
Increased
55

MICRON TECHNOLOGY INC

58.2M$16.6B2.3%$94.04+211.17%
22 qtrssince 2020-Q3
Decreased
0

ELI LILLY & CO

15M$16.2B2.2%$228.45+368.17%
27 qtrssince 2019-Q2
Increased
55

VERTEX PHARMACEUTICALS INC

25.5M$11.6B1.6%$304.84+48.85%
27 qtrssince 2019-Q2
Decreased
0

ALPHABET INC-CL C

28.8M$9.1B1.2%$109.57+187.08%
27 qtrssince 2019-Q2
Increased
51

VISA INC-CLASS A SHARES

24.5M$8.6B1.2%$232.33+50.05%
27 qtrssince 2019-Q2
Decreased
0

NETFLIX INC

89.3M$8.4B1.1%$87.43+7.26%
27 qtrssince 2019-Q2
Increased
81
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

27.4M$8.3B1.1%$67.09+346.55%
27 qtrssince 2019-Q2
Decreased
0

AMAZON.COM INC

33.8M$7.8B1.1%$179.75+29.37%
27 qtrssince 2019-Q2
Decreased
0

BANK OF AMERICA CORP

141.3M$7.8B1.1%$38.29+44.37%
27 qtrssince 2019-Q2
Decreased
0

SHOPIFY INC - CLASS A

47.8M$7.7B1.0%$61.30+167.12%
27 qtrssince 2019-Q2
Decreased
0

AMGEN INC

23.1M$7.6B1.0%$288.12+13.30%
6 qtrssince 2024-Q3
Increased
61

APPLE INC

27.5M$7.5B1.0%$204.98+32.27%
27 qtrssince 2019-Q2
Increased
65

UNITEDHEALTH GROUP INC

22.6M$7.5B1.0%$263.98+25.83%
27 qtrssince 2019-Q2
Increased
52
$735.3B
AUM
574
Positions
Q4 2025
Filing
Rating · 4.0
Quarterly Portfolio Change
+5%Q3'24$645B+2%Q4'24$658.7B-6%Q1'25$617.2B+11%Q2'25$687.9B+6%Q3'25$732B+0%Q4'25$735.3B
Activity profile
$ moved · Q4'25
New7%Increased42%Decreased48%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.0 years
<1Q5%1-4Q12%1-2Y13%2Y+70%

Capital World Investors manages $735.3B across 574 positions as of Q4 2025. Top holdings: AVGO (5.8%), MSFT (4.2%), META (3.6%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q4 2025 Summary

Active quarter - 47 new positions, 41 exits, 257 increased. Top move: NFLX (INCREASED, conviction 81). Portfolio: $735.3B across 574 positions.

Top holdings by portfolio weight

Total AUM$735B
AVGO5.80%
MSFT4.24%
META3.55%
NVDA3.32%
PM2.89%
TSLA2.60%
GOOGL2.29%
MU2.26%
LLY2.20%
VRTX1.57%
Other1.23%

Portfolio allocation by GICS sector

Sectors11
Technology26.04%
Financial Services13.46%
Healthcare13.15%
Consumer Cyclical12.42%
Communication Services10.38%
Industrials10.25%
Consumer Defensive5.34%
Energy3.16%
Basic Materials2.99%
Utilities1.78%
Other1.02%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Financial Services, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record69
Conviction44
Concentration44
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
ESIESIELEMENT SOLUTIONS INC
Q3 2024 Q2 2026+1.7M shares+$124.1M
8Q
IONSIONSIONIS PHARMACEUTICALS INC
Q3 2024 Q2 2026+19.4M shares+$1.6B
8Q
NVRNVRNVR INC
Q3 2024 Q2 2026+564 shares-$27.4M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used